Kyorin Holdings Inc
TSE:4569

Watchlist Manager
Kyorin Holdings Inc Logo
Kyorin Holdings Inc
TSE:4569
Watchlist
Price: 1 499 JPY 2.18% Market Closed
Market Cap: 86.1B JPY
Have any thoughts about
Kyorin Holdings Inc?
Write Note

Kyorin Holdings Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kyorin Holdings Inc
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Kyorin Holdings Inc
TSE:4569
Cash Equivalents
ÂĄ14B
CAGR 3-Years
-24%
CAGR 5-Years
-20%
CAGR 10-Years
-6%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash Equivalents
ÂĄ859B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
2%
Daiichi Sankyo Co Ltd
TSE:4568
Cash Equivalents
ÂĄ707.7B
CAGR 3-Years
9%
CAGR 5-Years
19%
CAGR 10-Years
15%
Otsuka Holdings Co Ltd
TSE:4578
Cash Equivalents
ÂĄ515.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
1%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash Equivalents
ÂĄ462.9B
CAGR 3-Years
34%
CAGR 5-Years
21%
CAGR 10-Years
16%
Astellas Pharma Inc
TSE:4503
Cash Equivalents
ÂĄ302.9B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
-2%
No Stocks Found

Kyorin Holdings Inc
Glance View

Market Cap
86.1B JPY
Industry
Pharmaceuticals

KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.

Intrinsic Value
2 168.03 JPY
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Kyorin Holdings Inc's Cash Equivalents?
Cash Equivalents
14B JPY

Based on the financial report for Sep 30, 2024, Kyorin Holdings Inc's Cash Equivalents amounts to 14B JPY.

What is Kyorin Holdings Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-6%

Over the last year, the Cash Equivalents growth was -47%. The average annual Cash Equivalents growth rates for Kyorin Holdings Inc have been -24% over the past three years , -20% over the past five years , and -6% over the past ten years .

Back to Top